Protocol Ledger

NCT04974528 · Phase III · COMPLETED

Afrezza® INHALE-1 Study in Pediatrics

Interventional Phase III clinical trial protocol NCT04974528 sponsored by Mannkind in Endocrinology, Obesity, and Metabolic, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2021-09-29 Enrollment: 319 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT04974528
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)319 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04974528
Protocol FieldVerified Registry Value
NCT IdentifierNCT04974528
Consolidated Lead SponsorMannkind
Therapeutic Condition CohortEndocrinology, Obesity, and Metabolic
Clinical Trial PhasePhase III
Overall Recruitment StatusCOMPLETED
Registered Enrollment319 participants (ACTUAL)
Registered Start Date2021-09-29
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Endocrinology, Obesity, and Metabolic Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI